Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0490
-0.0010 (-2.00%)
Oct 29, 2025, 3:44 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 51.52 million as of October 29, 2025. Its market cap has increased by 45.41% in one year.
Market Cap
51.52M
Enterprise Value
44.60M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 51.52M, an increase of 800.06%. That is a compound annual growth rate of 8.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 51.52M | 27.96% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | 42.92M | 78.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.97B |
| Pro Medicus | 29.43B |
| Cochlear | 18.87B |
| Sonic Healthcare | 10.58B |
| Ramsay Health Care | 7.25B |
| Telix Pharmaceuticals | 5.56B |
| Ansell | 4.91B |
| Mesoblast | 3.28B |